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Increased Collagen VII Expression after Fractional Ablative Laser Treatment in
Recessive Dystrophic Epidermolysis Bullosa
Sasank Konda MD, Samantha Schneider MD, Marla Jahnke MD, Kristin Lieferman MD,
Marsha Chaffins MD, Andrew C. Krakowski MD, and David Ozog MD
Henry Ford Health System - Detroit, Michigan

Background: Recessive dystrophic epidermolysis bullosa (RDEB) is a genetic skin disorder
resulting in severe skin fragility, frequent blisters, scarring, increased risk of squamous cell
carcinomas, and decreased life expectancy. RDEB results from autosomal recessive mutations in
type VII collagen, which is a critical component of the basement membrane. Skin fragility can
predispose patients to great morbidity, and effective methods to prevent and treat these lesions are
limited.
Study Design / Methods: We report the case of a 27-year-old woman with a mosaic phenotype of
RDEB who presented for management of large non-healing chronic erosions on her upper back and
posterior neck. These areas were treated with deep fractional carbon dioxide (CO2) laser, which has
been shown to help with collagen remodeling in other clinical scenarios. Immediately after
treatment, topical poly-L-lactic acid (PLLA) was placed on the skin surface to act synergistically
with the laser. Additionally, punch biopsies were performed to compare the collagen distribution in
treated and untreated skin.
Results: After seven treatments, patient exhibited significant clinical improvement with decreased
bleeding during the procedure and decreased frequency of blistering. On hematoxylin and eosin
staining, the untreated skin featured abnormal collagen organization whereas the treated skin
demonstrated a collagen distribution akin to normal skin. Furthermore, a Herovici stain was
performed to differentiate mature (type I) versus immature (type III) collagen, with a notable shift
in expression patterns between the treated and untreated samples. Samples were also evaluated for
direct immunofluorescence for type VII collagen, which confirmed that the treated samples had
increased type VII collagen compared to the untreated sample.
Conclusions: This case illustrates the potential for fractional CO2 laser in combination with PLLA
to aid in the normalization of collagen and the potential for a “mechanical” treatment to increase
activity of collagen VII in select patients with RDEB.
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Background
• Recessive dystrophic epidermolysis bullosa (RDEB) is a genetic skin disorder
resulting in severe skin fragility, frequent blisters, scarring, increased risk of
squamous cell carcinomas and decreased life expectancy. RDEB results from
autosomal recessive mutations in type VII collagen, which is a critical component of
the basement membrane. Skin shearing can predispose patients to great morbidity,
and effective methods to prevent and treat these lesions are limited.
• Published case reports indicate that fractional laser therapy in patients with scars
aids in collagen remodeling and overall cosmesis. Fractional ablative laser therapy
also demonstrated accelerated wound healing in similar patients with RDEB.
Furthermore, the topical application of poly-l-lactic acid (PLLA) following
fractional ablative laser treatments likely has a synergistic role in both collagen
remodeling and cosmesis. We hypothesized that fractional ablative laser and topical
PLLA treatments may enhanced wound healing in patients with genetic alterations
in collagen, improve skin integrity, and loosen contracted skin.

On examination with hematoxylin and eosin staining, the untreated skin specimen
demonstrated a detached epidermis with dermal fibrosis and chronic inflammation, and
the treated skin specimen showed scarring, fibrosis and chronic dermal inflammation,
with an intact epidermis (Figures 2A and 2B, respectively). Additionally, in the treated
specimen, the epidermis demonstrates compact hyperkeratosis (2B). Notably, with
respect to the collagen organization, the specimen from untreated skin demonstrated
thick, jumbled collagen (Figure 2A), whereas the specimen from treated skin had finer
collagen with more definite “east-west” organization (Figure 2B). On examination with
Herovici staining that differentiates mature type I (pink) and immature type III (blue)
collagen, treated skin demonstrated an increase in type I collagen (Figures 2C and 2D).
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Results
• Fractional ablative laser treatments in this patient have resulted in considerable
clinical improvement including thickening of the dermis, which resulted in
decreased intraoperative bleeding (Figure 1B). Since the time of treatment, the
patient has reported marked improvement with a decreased number of erosions as
well as decreased pain. On hematoxylin and eosin staining, the untreated skin had
abnormal collagen organization whereas the treated skin demonstrated a more
organized scar-like pattern. Furthermore, a Herovici stain was performed to
differentiate mature (type I) versus immature (type III) collagen; increased
collagen type I was noted in the treated specimen. Specimens also were evaluated
by indirect immunofluorescence for type VII collagen, which demonstrated that
type VII collagen was detected in the specimen from treated affected skin
compared to the untreated sites.

Conclusions
• This case illustrates the potential for a “mechanical” treatment, fractional CO2
laser with topical PLLA, in certain patients with RDEB as an adjunctive measure
in their care. It is unclear whether the benefit is a result of scarification of the
treated area versus the normalization of collagen (i.e., apparent induction of
collagen VII expression).
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been using topical wound care under the care of Dermatology without significant
improvement. Physical examination revealed a 15 x 12 cm erythematous crusted
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energy and 15% density were sequentially administered (15 treatments over two
years). Immediately after each treatment, concentrated topical PLLA was applied to
the treated area. Punch biopsy specimens were obtained from treated and untreated
affected skin after the seventh treatment for histopathologic examination.

Indirect immunofluorescence studies to detect collagen VII were additionally
performed on biopsy specimens from the patient’s untreated affected skin and treated
affected skin using serum with known IgG collagen VII antibodies using fluorescein
isothiocyanate-conjugated antibody to human IgG as the secondary/detection antibody.
The treated affected skin (Figure 3B) shows that collagen VII is detected along the
basement membrane zone (BMZ, white arrowheads) whereas the untreated affected
skin does not.
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